Jessica Liu, MD, PhD, who recently joined the Department of Anesthesia, Critical Care and Pain Medicine (DACCP), has been named a 2025 STAT Wunderkind, an honor that celebrates the most promising early-career researchers in health and medicine across North America.
As a new faculty member, Dr. Liu aims to connect the bioengineering and clinical worlds—applying AI, device innovation, and translational science to personalize anesthesia and improve care delivery across all settings.
Dr. Simon Robson, Director of Research at DACCP, spoke about Dr. Liu’s accomplishments:
“What distinguishes Dr. Liu is her remarkable ability to integrate rigorous engineering innovation with clinically relevant problem-solving. Given the increasing need to link new developments in technology and clinical medicine, Dr. Liu embodies the next generation of clinician-(bio)engineers who are redefining precision care. She is not only a Wunderkind in title but in fact—merging invention, scholarship, and compassion with clarity of vision.”
